Functional results of total-knee arthroplasty versus medial unicompartmental arthroplasty: two-year results of a randomised, assessor-blinded multicentre trial.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
23 06 2021
Historique:
entrez: 24 6 2021
pubmed: 25 6 2021
medline: 29 6 2021
Statut: epublish

Résumé

The primary objective of the trial was to assess the clinical effectiveness of medial unicompartmental knee arthroplasty versus total knee arthroplasty in patients with isolated medial osteoarthritis of the knee. Prospective, randomised, 2 years, assessor-blind, multicentre, superiority trial. The patients were enrolled between December 2015 and May 2018 from the outpatient clinics of three public high-volume arthroplasty hospitals (Finland). We recruited 143 patients with symptomatic-isolated medial osteoarthritis of the knee needing an arthroplasty procedure. All the patients were suitable for both unicompartmental and total knee arthroplasties. Population was selected as the end-stage-isolated medial osteoarthritis. All patients, randomized 1:1, received a medial unicompartmental arthroplasty or a total knee arthroplasty through a similar midline skin incision. Patients were blinded to the type of arthroplasty for the whole 2 years of follow-up. Primary outcome measure was between-group differences in the Oxford Knee Score (OKS) and secondary outcome Knee injury and Osteoarthritis Score (KOOS) at 2 years postoperatively. The changes within and between the groups were analysed with analysis of variance for repeated measurements. The primary outcome was comparable for medial unicompartmental arthroplasty and total knee arthroplasty at 2 years. The mean difference in the OKS between the groups was 1.6 points (95% CI -0.7 to 3.9). In the KOOS subscales, the mean difference between the groups was 0.1 points (95% CI -4.8 to 5.0) for pain, 7.8 points (95% CI 1.5 to 14.0) for symptoms, 4.3 points (95% CI -0.6 to 9.2) for function in daily living, 4.3 points (95% CI -3.0 to 11.6) for function in sports, and 2.1 points (95% CI -4.8 to 9.1) for knee-related quality of life. The recovery after unicompartmental knee arthroplasty was faster compared with total knee arthroplasty, but unicompartmental arthroplasty did not provide a better patient-reported outcome at 2 years. NCT02481427.

Identifiants

pubmed: 34162649
pii: bmjopen-2020-046731
doi: 10.1136/bmjopen-2020-046731
pmc: PMC8231055
doi:

Banques de données

ClinicalTrials.gov
['NCT02481427']

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

e046731

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Arthroplasty. 2017 May;32(5):1460-1469
pubmed: 28065624
J Clin Epidemiol. 2015 Jan;68(1):73-9
pubmed: 25441700
N Engl J Med. 2015 Oct 22;373(17):1597-606
pubmed: 26488691
J Rheumatol. 2019 Sep;46(9):1134-1140
pubmed: 30988126
Acta Orthop. 2008 Apr;79(2):174-83
pubmed: 18484242
Fam Pract. 2005 Feb;22(1):103-8
pubmed: 15640302
J Surg Orthop Adv. 2015 Winter;24(4):252-6
pubmed: 26731390
Clin Orthop Relat Res. 2012 Jan;470(1):3-19
pubmed: 22045067
J Bone Joint Surg Br. 2009 Jan;91(1):52-7
pubmed: 19092004
Acta Orthop. 2011 Apr;82(2):131-5
pubmed: 21434760
Lancet. 2019 Aug 31;394(10200):746-756
pubmed: 31326135
BMJ. 2019 Feb 21;364:l352
pubmed: 30792179
J Arthroplasty. 2012 Sep;27(8 Suppl):86-90
pubmed: 22560653
Arthritis Rheum. 2012 Feb;64(2):423-8
pubmed: 22252250
J Bone Joint Surg Br. 2003 Sep;85(7):937-42
pubmed: 14516022
Knee. 2012 Mar;19(2):103-6
pubmed: 21345681
Clin Orthop Relat Res. 2010 Jan;468(1):57-63
pubmed: 19844772
J Bone Joint Surg Br. 2010 Dec;92(12):1628-31
pubmed: 21119165
Knee. 2019 Jun;26(3):768-773
pubmed: 30929792
Int J Epidemiol. 2014 Aug;43(4):1272-83
pubmed: 24881045
Lancet. 2012 Apr 7;379(9823):1331-40
pubmed: 22398175
Clin Orthop Relat Res. 2009 Jun;467(6):1450-7
pubmed: 19225852
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
J Knee Surg. 2011 Dec;24(4):273-8
pubmed: 22303756
Ann Med. 2001 Jul;33(5):328-36
pubmed: 11491191
Health Qual Life Outcomes. 2003 Nov 03;1:64
pubmed: 14613558
EFORT Open Rev. 2018 Jun 6;3(6):363-373
pubmed: 30034817
Health Qual Life Outcomes. 2003 May 25;1:17
pubmed: 12801417

Auteurs

Jani Knifsund (J)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland Jani.Knifsund@tyks.fi.
Department of Clinical Medicine, University of Turku, Turku, Finland.

Tuukka Niinimaki (T)

Department of Surgery, Oulu University Hospital, Oulu, Finland.

Heikki Nurmi (H)

Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.

Alar Toom (A)

Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.

Hannes Keemu (H)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland.

Inari Laaksonen (I)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland.
Department of Clinical Medicine, University of Turku, Turku, Finland.

Matti Seppänen (M)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland.

Antti Liukas (A)

Department of Anesthesiology, Turku University Hospital, Turku, Finland.

Konsta Pamilo (K)

Department of Surgery, Central Finland Central Hospital, Jyväskylä, Finland.

T Vahlberg (T)

Department of Clinical Medicine, University of Turku, Turku, Finland.

Ville Äärimaa (V)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland.

K T Mäkelä (KT)

Department of Orthopedics and Traumatology, Turku University Hospital, Turku, Finland.
Department of Clinical Medicine, University of Turku, Turku, Finland.
National Institute for Health and Welfare, The Finnish Arthroplasty Register, Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH